Caprolactam Chemicals Ltd
Caprolactam Chemicals Limited was promoted as Vamotiwala Chemicals Industries Limited as a small scale industry in the year 1992. The company specializes in the manufacturing of industrial chemicals like Glycol Ethers and Ethylene Oxide Condensate Emulsifiers. Caprolactam Chemicals has customer base only in India.
- Market Cap ₹ 26.2 Cr.
- Current Price ₹ 56.9
- High / Low ₹ 73.2 / 44.2
- Stock P/E 131
- Book Value ₹ 12.1
- Dividend Yield 0.00 %
- ROCE 6.86 %
- ROE 3.67 %
- Face Value ₹ 10.0
Pros
- Promoter holding has increased by 1.37% over last quarter.
Cons
- Stock is trading at 4.72 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 6.04% over past five years.
- Company has a low return on equity of 11.4% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
3.38 | 3.92 | 2.85 | 4.88 | 3.23 | 4.07 | 5.19 | 6.51 | 6.31 | 2.07 | 9.84 | 6.96 | |
2.71 | 4.03 | 2.46 | 4.05 | 2.76 | 3.18 | 3.31 | 3.99 | 4.14 | 2.64 | 5.17 | 4.79 | |
Operating Profit | 0.67 | -0.11 | 0.39 | 0.83 | 0.47 | 0.89 | 1.88 | 2.52 | 2.17 | -0.57 | 4.67 | 2.17 |
OPM % | 19.82% | -2.81% | 13.68% | 17.01% | 14.55% | 21.87% | 36.22% | 38.71% | 34.39% | -27.54% | 47.46% | 31.18% |
0.05 | 0.01 | -0.15 | 0.40 | 0.01 | 0.07 | 0.07 | 0.06 | 0.09 | 0.41 | 0.02 | 0.18 | |
Interest | 0.00 | 0.00 | 0.06 | 0.11 | 0.12 | 0.19 | 0.34 | 0.30 | 0.30 | 0.28 | 0.57 | 0.50 |
Depreciation | 0.22 | 0.19 | 0.23 | 0.51 | 0.47 | 0.57 | 0.97 | 1.02 | 1.07 | 1.03 | 1.15 | 1.58 |
Profit before tax | 0.50 | -0.29 | -0.05 | 0.61 | -0.11 | 0.20 | 0.64 | 1.26 | 0.89 | -1.47 | 2.97 | 0.27 |
Tax % | 16.00% | 6.90% | 0.00% | 14.75% | 0.00% | 15.00% | 23.44% | 24.60% | 26.97% | 12.93% | 14.14% | 29.63% |
0.42 | -0.27 | -0.06 | 0.52 | -0.12 | 0.17 | 0.50 | 0.95 | 0.65 | -1.28 | 2.55 | 0.20 | |
EPS in Rs | 0.91 | -0.59 | -0.13 | 1.13 | -0.26 | 0.37 | 1.09 | 2.07 | 1.41 | -2.78 | 5.54 | 0.43 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 6% |
3 Years: | 3% |
TTM: | -29% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | -17% |
3 Years: | -32% |
TTM: | -92% |
Stock Price CAGR | |
---|---|
10 Years: | 23% |
5 Years: | 43% |
3 Years: | -18% |
1 Year: | -4% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 16% |
3 Years: | 11% |
Last Year: | 4% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.59 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 | 4.60 |
Reserves | -2.81 | -3.08 | -3.13 | -2.61 | -2.73 | -2.56 | -2.06 | -1.10 | -0.52 | -1.80 | 0.74 | 0.95 |
0.02 | 0.09 | 0.82 | 0.95 | 1.37 | 1.89 | 3.58 | 2.45 | 2.15 | 3.76 | 5.69 | 5.86 | |
0.40 | 0.52 | 1.15 | 0.98 | 1.10 | 2.35 | 1.29 | 1.16 | 0.97 | 3.77 | 0.49 | 0.24 | |
Total Liabilities | 2.20 | 2.12 | 3.43 | 3.91 | 4.33 | 6.27 | 7.41 | 7.11 | 7.20 | 10.33 | 11.52 | 11.65 |
1.38 | 1.19 | 2.92 | 2.96 | 3.38 | 3.56 | 6.37 | 6.07 | 5.50 | 5.26 | 10.22 | 10.29 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.96 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
0.82 | 0.93 | 0.51 | 0.95 | 0.95 | 2.71 | 1.04 | 1.04 | 1.70 | 1.11 | 1.30 | 1.36 | |
Total Assets | 2.20 | 2.12 | 3.43 | 3.91 | 4.33 | 6.27 | 7.41 | 7.11 | 7.20 | 10.33 | 11.52 | 11.65 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.56 | -0.13 | 1.44 | 0.58 | 0.54 | 1.10 | 2.96 | 2.18 | 1.25 | 3.05 | 0.86 | 1.82 | |
0.00 | 0.00 | -2.16 | -0.56 | -0.89 | -0.75 | -3.78 | -0.73 | -0.48 | -4.75 | -2.14 | -1.64 | |
-0.52 | 0.07 | 0.68 | 0.02 | 0.30 | 0.33 | 0.35 | -1.43 | -0.59 | 1.33 | 1.37 | -0.32 | |
Net Cash Flow | 0.04 | -0.06 | -0.05 | 0.05 | -0.05 | 0.68 | -0.47 | 0.02 | 0.18 | -0.37 | 0.08 | -0.14 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 32.40 | 25.14 | 1.28 | 38.89 | 40.68 | 69.05 | 2.81 | 16.82 | 27.19 | 5.29 | 25.22 | 33.56 |
Inventory Days | 104.29 | 304.17 | 88.78 | 82.64 | 53.85 | 52.14 | ||||||
Days Payable | 43.45 | 861.81 | 799.05 | 344.34 | 173.52 | 111.73 | ||||||
Cash Conversion Cycle | 32.40 | 85.97 | 1.28 | 38.89 | 40.68 | -488.58 | -707.46 | 16.82 | 27.19 | -256.41 | -94.45 | -26.03 |
Working Capital Days | 38.88 | 28.86 | -84.53 | -0.75 | -14.69 | -62.78 | -22.50 | -20.75 | 17.93 | -513.12 | 17.80 | 40.38 |
ROCE % | 27.10% | -17.06% | 11.34% | 27.64% | 0.32% | 10.91% | 19.52% | 25.85% | 19.54% | -18.61% | 40.25% |
Documents
Announcements
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6h
- Closure of Trading Window 29 Jun
- Revised Result Filing For The Year Ended 31St March , 2024. This Is With Reference To The Corporate Announcement Submitted By Our Company Dated 27-May-2024 04:54:04 PM Under Regulation 30 Of SEBI (LODR) Regulations, 2015, Exchange Has Observed That The Required Details Under SEBI Circular Dated July 13, 2023, For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015. - Board Meeting Commencement Time Not Provided. With Reference For To The Same Doing Revised Filing For The Financial Result Filing For Year Ended 31St March 2024, Kindly Take In Yours Record. 24 Jun
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
29 May - Year ended 31st March 2024 results publication
- Announcements Under Regulation 30 SEBI (LODR) For Appointment Of Internal Auditor Of The Company For F.Y. 2024-25 27 May
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview [1]
Caprolactam Chemicals is engaged in manufacturing of chemicals and provides Job work services as per customers requirement.
Caprolactam offers ready to use facilities for Contract Manufacturing to the industries like Flavors & Fragrance, Aroma, Pharma & Agro-Chemicals.
Company did 6.5 Cr turnover in FY20 which was jobwork income.